MARKET

VRPX

VRPX

Virpax Pharmaceuticals Inc
NASDAQ
0.1300
-0.0390
-23.08%
After Hours: 0.1814 +0.0514 +39.54% 19:59 03/18 EDT
OPEN
0.1300
PREV CLOSE
0.1690
HIGH
0.1353
LOW
0.1244
VOLUME
18.17M
TURNOVER
--
52 WEEK HIGH
4.825
52 WEEK LOW
0.1244
MARKET CAP
3.45M
P/E (TTM)
-0.0458
1D
5D
1M
3M
1Y
5Y
1D
Virpax Reveals Results From A Beagle Dog Dose Range Finding Study; All The Dogs In DRF Study Demonstrated Positive Tolerance To Probudur And No Adverse Effects Were Noted
Benzinga · 6h ago
VIRPAX PHARMACEUTICALS INC - DOSES OF LBL100 UP TO 90 MG/KG WELL TOLERATED BY BEAGLE DOGS
Reuters · 6h ago
VIRPAX RECEIVES POSITIVE PROBUDUR™ RESULTS FOR DOSE RANGE STUDY MOVES TOWARDS NEXT STEPS IN IND
Reuters · 6h ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 9h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 14h ago
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Benzinga · 16h ago
*Virpax Pharmaceuticals Files for a Stock Offering
Dow Jones · 1d ago
Weekly Report: what happened at VRPX last week (0310-0314)?
Weekly Report · 1d ago
More
About VRPX
Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on developing novel and proprietary drug delivery systems across various pain indication. Its drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (CNS) disorders to enhance patients’ quality of life. Its portfolio consists of multiple preclinical stage product candidates: Epoladerm, Probudur, Envelta, AnQlar and NobrXiol. Probudur is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain. Envelta is an intranasal molecular envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer. The NobrXiol is being developed for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management of rare pediatric epilepsy.

Webull offers Virpax Pharmaceuticals Inc stock information, including NASDAQ: VRPX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRPX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRPX stock methods without spending real money on the virtual paper trading platform.